38 patients in the thrombocytosis group were treated with anti-TNF-α therapy, and among them 35 patients were treated with etanercept, 2 patients were treated with adalimumab and 1 patient was treated with infliximab. The gene discussed is TNF; the disease is thrombocytosis disease.